XTX Topco’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Other funds holding JAZZ
XTX Topco's JAZZ Position: Q2 2026 in Review
XTX Topco increased its Jazz Pharmaceuticals (JAZZ) stake by 76% in Q2 2026, buying an estimated $2.88M and bringing the position to 30,496 shares worth $7.35M. The position accounts for 0.1% of the portfolio, ranked #215.
XTX Topco first reported a position in JAZZ in Q2 2022 and has held it in 11 quarters since. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.
- XTX Topco held 30,496 shares of Jazz Pharmaceuticals worth $7.35M as of Q2 2026.
- XTX Topco bought 13,160 Jazz Pharmaceuticals shares in Q2 2026, an estimated $2.88M.
- Jazz Pharmaceuticals made up 0.1% of XTX Topco's portfolio in Q2 2026, its #215 holding.
- XTX Topco first reported a position in Jazz Pharmaceuticals in Q2 2022 and has held it in 11 quarters since.
- 646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.
Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.